Lester J. Peters - Concepedia

Author

Lester J. Peters

The University of Texas MD Anderson Cancer Center

Also Known As

L J Peters, Lester J Peters, Lester J. Peters

263

Publications

17.6K

Citations

H-Index

121

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Peter MacCallum Cancer Centre Anderson Hospital Radiation Oncology Associates The University of Texas System

About

Lester J. Peters is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	50	95	9.4K
2	Health Sciences	38	52	4.6K
3	Engineering	7	7	1.2K
4	Public Health	2	2	475
5	Social Sciences	1	1	62

Lester J. Peters

140

Publications

16K

Citations

H-Index

Page 1

	Year	Citations
Prevention of Second Primary Tumors with Isotretinoin in Squamous-Cell Carcinoma of the Head and Neck Waun Ki Hong, S. M. Lippman, Loretta M. Itri, New England Journal of Medicine	1990	1.4K
Changes in early and late radiation responses with altered dose fractionation: Implications for dose-survival relationships Howard D. Thames, H. Rodney Withers, Lester J. Peters, International Journal of Radiation OncologyBiologyPhysics Radiation OncologyEngineeringRadiation EffectRadiation ExposureRadiation Dose	1982	840
Critical Impact of Radiotherapy Protocol Compliance and Quality in the Treatment of Advanced Head and Neck Cancer: Results From TROG 02.02 Lester J. Peters, Brian O’Sullivan, J. Giralt, Journal of Clinical Oncology	2010	791
Prognostic Significance of p16 <sup>INK4A</sup> and Human Papillomavirus in Patients With Oropharyngeal Cancer Treated on TROG 02.02 Phase III Trial Danny Rischin, Richard J. Young, Richard Fisher, Journal of Clinical Oncology	2010	738
Prognostic Significance of [<sup>18</sup>F]-Misonidazole Positron Emission Tomography–Detected Tumor Hypoxia in Patients With Advanced Head and Neck Cancer Randomly Assigned to Chemoradiation With or Without Tirapazamine: A Substudy of Trans-Tasman Radiation Oncology Group Study 98.02 Danny Rischin, Rodney J. Hicks, Richard Fisher, Journal of Clinical Oncology	2006	540
The influence of positive margins and nerve invasion in adenoid cystic carcinoma of the head and neck treated with surgery and radiation Adam S. Garden, Randal S. Weber, William H. Morrison, International Journal of Radiation OncologyBiologyPhysics Neuro-oncologySurgical OncologyNerve InvasionNasopharyngeal CancerSkull Base Surgery	1995	454
Radiation Dose and Second Cancer Risk in Patients Treated for Cancer of the Cervix John D. Boice, Ruth A. Kleinerman, Maria Blettner, Radiation Research Cancer ManagementRadiation ExposureGynecologyDose ResponseGynecology Oncology	1988	397
Tirapazamine, Cisplatin, and Radiation Versus Cisplatin and Radiation for Advanced Squamous Cell Carcinoma of the Head and Neck (TROG 02.02, HeadSTART): A Phase III Trial of the Trans-Tasman Radiation Oncology Group Danny Rischin, Lester J. Peters, Brian O’Sullivan, Journal of Clinical Oncology	2010	370
International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma Anne W.M. Lee, Wai Tong Ng, Jianji Pan, Radiotherapy and Oncology Tumor BiologyMedicineCancer ManagementNasopharyngeal CancerInternational Guideline	2017	359
A new isoeffect curve for change in dose per fraction H. Rodney Withers, Howard D. Thames, Lester J. Peters Radiotherapy and Oncology MedicineBiostatisticsPharmacotherapyToxicologyDosimetry	1983	352

Page 1